Daewoong Pharmaceutical Co (XKRX:069620) Selling and Marketing Expense : ₩231,305 Mil (TTM As of Mar. 2025)

View and export this data going back to 2002. Start your Free Trial

What is Daewoong Pharmaceutical Co Selling and Marketing Expense?

Selling and Marketing Expense is the aggregate total amount of expenses directly related to the marketing or selling of products or services. Daewoong Pharmaceutical Co's Selling and Marketing Expense for the three months ended in Mar. 2025 was ₩67,217 Mil. Its Selling and Marketing Expense for the trailing twelve months (TTM) ended in Mar. 2025 was ₩231,305 Mil.

Daewoong Pharmaceutical Co Selling and Marketing Expense Historical Data

The historical data trend for Daewoong Pharmaceutical Co's Selling and Marketing Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Daewoong Pharmaceutical Co Selling and Marketing Expense Chart

Daewoong Pharmaceutical Co Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Selling and Marketing Expense

Get a 7-Day Free Trial

188,701.17

196,054.44

225,004.92

235,758.62

245,896.74

Daewoong Pharmaceutical Co Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Selling and Marketing Expense	Get a 7-Day Free Trial															70,539.16	62,348.42	70,620.54	31,119.27	67,216.70

Daewoong Pharmaceutical Co Selling and Marketing Expense Calculation

Selling and Marketing Expense is the aggregate total amount of expenses directly related to the marketing or selling of products or services.

Selling and Marketing Expense for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩231,305 Mil.

Daewoong Pharmaceutical Co Selling and Marketing Expense Related Terms

Thank you for viewing the detailed overview of Daewoong Pharmaceutical Co's Selling and Marketing Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

Daewoong Pharmaceutical Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Daewoong Pharmaceutical Co Ltd (XKRX:069620) » Definitions » Selling and Marketing Expense

Traded in Other Exchanges

N/A

Address

12, Bongeunsa-ro 114-gil, Daewoong Pharmaceutical Building, Gangnam-gu, Seoul, KOR

Website

https://www.daewoong.co.kr

Daewoong Pharmaceutical Co Ltd develops, manufactures and sells prescription drug products. The company's product portfolio comprises products such as Moxicle, Plunazol Cap, Bearcef tab, Newdizime etc. It develops and promotes brands such as Ursa, Nabota, Luphere, Easyef, Cretropin. The company has manufacturing facilities at Hyangnam and Sungnam.

Daewoong Pharmaceutical Co Headlines

No Headlines